Spanish company Vilynx have closed a $ 460K seed round which will help them to better tune their products to their main potential clients. “The HTIP programme has been very effective in setting contacts with different VC's we met during the Brussels and Alpine Venture sessions. We have extended our seed investment by $400K leveraging from $1.7M to $2.1M in order to allow one of our customers (Publisher) to move from partner to Strategic Investor “, said Vilynx Co-Founder & EU Manager Oscar Chabrera.
The Swedish company Ascatron AB raised its first investment from international investors and the money will be used to bring their technology to the market.‘We are very pleased to having Quadrivio and Como Venture taking lead on our current A-round fund raising”, said Christian Vieider, CEO of Ascatron. “The money will be used to bring the Buried Grid technology for next generation high performance SiC Power electronic devices to the market”.
Evonik Industries has invested in the start-up company SYNOSTE Oy via its venture capital arm and now holds a minority share in the medical technology company based in Düsseldorf (Germany) and Helsinki (Finland). The investment was made as part of a series A round, together with High-Tech Gründerfonds, two Finnish venture capital funds Finnvera and Lifeline Ventures as well as Finnish business angels. The overall volume of the financing round lies in the single-digit million euro range. "We are happy to have found a strategic partner in Evonik, who is supporting us in this important phase with its material competence," explains Harri Hallila, CEO and co-founder of SYNOSTE. With the funds from the current financing round, SYNOSTE is primarily aiming to move forward to the clinical tests. The company intends to develop its Düsseldorf site into the European sales center due to its good infrastructure and location.